NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.16 billion as of May 20, 2026. Its market cap has increased by 14.85% in one year.

Market Cap

1.16B

Enterprise Value

1.42B

1-Year Change

14.85%

Ranking

#2473

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.16B, an increase of 14,569.43%. That is a compound annual growth rate of 25.21%.

Market Cap History

Date	Market Cap	% Change
May 19, 2026	1.09B	-28.20%
Dec 31, 2025	1.52B	-28.07%
Dec 31, 2024	2.12B	2.57%
Dec 29, 2023	2.06B	76.73%
Dec 30, 2022	1.17B	-72.22%
Dec 31, 2021	4.20B	-29.72%
Dec 31, 2020	5.98B	95.74%
Dec 31, 2019	3.05B	160.37%
Dec 31, 2018	1.17B	64.64%
Dec 29, 2017	712.40M	5.87%
Dec 30, 2016	672.90M	41.66%
Dec 31, 2015	475.00M	89.92%
Dec 31, 2014	250.10M	41.06%
Dec 31, 2013	177.30M	57.88%
Dec 31, 2012	112.30M	85.62%
Dec 30, 2011	60.50M	24.49%
Dec 31, 2010	48.60M	-12.90%
Dec 31, 2009	55.80M	189.12%
Dec 31, 2008	19.30M	-43.07%
Dec 31, 2007	33.90M	-16.30%
Dec 29, 2006	40.50M	841.86%
Dec 30, 2005	4.30M	-20.37%
Dec 31, 2004	5.40M	-31.65%
Mar 16, 2004	7.90M	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veracyte	3.07B
Twist Bioscience	3.06B
GRAIL	2.56B
Adaptive Biotechnologies	2.05B
GeneDx Holdings	1.21B
CareDx	1.03B
OPKO Health	830.60M
Personalis	666.03M

Market Cap Rankings